Sharps Technology, Inc. (STSS) は上場企業です ヘルスケア セクターの Medical - Instruments & Supplies 業界で事業展開. 本社所在地は Melville, NY, アメリカ. 現CEOは Paul Kruger Danner.
STSS を有する IPO日 2022-04-14, 55 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $44.4M.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
